Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Itonis Inc. (ITNS) Message Board

Latest Itonis Inc (ITNS) Headlines Itonis Pha

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 109
Posted On: 03/10/2014 7:35:54 AM
Avatar
Posted By: Stock_Tracker
Latest Itonis Inc (ITNS) Headlines



Itonis Pharmaceuticals Received Emesyl Samples for Evaluation

Marketwire - Fri Feb 28, 12:50PM CST

Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has received and is currently evaluating samples of its Emesyl(TM) product from its manufacturer. Oasis Health Products, Inc. delivered two versions of the Emesyl(TM) anti-nausea formula which are currently being evaluating for tolerance.



Itonis Pharmaceuticals Appoints New Scientific Officer to Guide Clinical Process for Homeopathic Products

Marketwire - Mon Dec 09, 9:00AM CST

Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce today the addition of Ernesto Barron to Dr. Hensley's product development team. Mr. Barron will serve as Itonis Phamaceuticals' Chief Scientific Officer and Director of Clinical Research.



Itonis Pharmaceuticals Completed Packaging Graphics for Its Emesyl Brand of Nausea Remedy

Marketwire - Wed Dec 04, 9:58AM CST

Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has completed packaging graphics for its Emesyl(TM) Nausea Remedy.



Itonis Pharmaceuticals to Conduct Case Study for Its Emesyl Brand of Nausea Remedy

Marketwire - Mon Dec 02, 9:00AM CST

Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company will conduct a case study to confirm the efficacy of its Emesyl(TM) Nausea Remedy in a clinical setting.



Itonis Pharmaceuticals and Dr. Charles Hensley to Receive Delivery of First Production Batch of Emesyl(TM) Nausea Remedy

Marketwire - Mon Nov 25, 9:00AM CST

Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are to receive first batch of Emesyl(TM) product, the Company's over-the-counter homeopathic product for the relief of nausea.



Itonis Pharmaceuticals and Dr. Charles Hensley Hitting Production Milestones for Protection of Emesyl(TM) Nausea Remedy

Marketwire - Mon Nov 18, 8:50AM CST

Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to release their manufacturing update for Emesyl(TM), the Company's over-the-counter homeopathic product for the relief of nausea.



Itonis Pharmaceuticals to Trademark Emesyl Nausea Relief Remedy

Marketwire - Thu Oct 24, 9:30AM CDT

Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has applied to the USPTO to trademark its Emesyl brand for its homeopathic pharmaceutical nausea relief remedy. The Company's application has been assigned Serial No. 86099093.



Itonis Pharmaceuticals and Charles Hensley, Ph.D. to Begin Distributing Emesyl(TM) Anti-Nausea Homeopathic Product in Mexico

Marketwire - Thu Sep 12, 7:30AM CDT

Itonis, Inc.'s pharmaceutical division (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, are pleased to announce that Hensley Brothers Distribution, LLC ("HBD") will distribute Emesyl((TM)), the Company's over-the-counter homeopathic product for nausea relief, to Mexico through one of HBD's distribution partners.



Itonis Pharmaceuticals, Led by Dr. Charles Hensley, the Inventor of Zicam(R) Cold Remedy, Received FDA Labeler Status

Marketwire - Wed Jul 31, 8:02AM CDT

Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has received its labeler's code from the federal Food and Drug Administration (FDA).



Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals to Distribute Homeopathic Products in Retail Chains

Marketwire - Fri Jul 19, 8:45AM CDT

Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company's line of homeopathic products will be distributed nationally and internationally by Hensley Brothers Distribution, LLC.



Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals to Obtain FDA Labeler Status

Marketwire - Tue Jun 25, 1:30PM CDT

Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce the Company has commenced the application process to file with the U.S. Food and Drug Administration as a labeler.



Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy, And Itonis Pharmaceuticals Prepared to File for the National Drug Code Number for the Emesyl(tm) Anti-Nausea Products to Launch Sales in Fall 2013

GlobeNewswire - Fri May 31, 8:30AM CDT

Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the Company is prepared to file for the National Drug Code (NDC) number for their over-the-counter Emesyl(TM) homeopathic product.



Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy And Itonis Pharmaceuticals to Finalized Product Packaging For The Emesyl Anti-Nausea Products

GlobeNewswire - Thu May 30, 11:53AM CDT

Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the finalization of the packaging graphics for their over-the-counter homeopathic product EmesylTM which can be viewed at the Company's website at www.itonisholdings.com.



Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy And Itonis Pharmaceuticals Finalized Product Packaging For The Emesyl Anti-Nausea Products

GlobeNewswire - Thu May 30, 10:00AM CDT

Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the finalization of the packaging graphics for their over-the-counter homeopathic product EmesylTM which can be viewed at the Company's website at www.itonisholdings.com.



Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy and Itonis Pharmaceuticals to Use Its Exclusive Manufacturer for Emesyl(TM) Anti-Nausea Swab and Oral Spray Products

GlobeNewswire - Fri May 03, 8:55AM CDT

Itonis, Inc. (OTC:ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce that the Company's exclusive manufacturer (Oasis Health Products, Inc.) will produce the Company's anti-nausea swab and its oral spray products under the Emesyl(TM) brand.



Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy and Itonis Pharmaceuticals Enter Into Exclusive Agreement With Manufacturer for Anti-Nausea Spray Products

GlobeNewswire - Fri May 03, 5:53AM CDT

Itonis, Inc. (OTC:ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce that the Company's manufacturer (Oasis Health Products, Inc.) has agreed to manufacture nasal spray, oral spray and nasal swab delivery form products for the relief and treatment of nausea for Itonis, Inc. exclusively.



Oasis Health Products to Provide Manufacturing Services for Itonis Pharmaceuticals' Anti-Nausea Products

GlobeNewswire - Thu May 02, 3:25PM CDT

Itonis, Inc. (OTC:ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce that the Company has entered into a manufacturing agreement with Oasis Health Products, Inc. to manufacture Emesyl(TM), the company's over-the-counter homeopathic products for the relief of nausea.



Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals Add Sublingual Spray Application to Anti-Nausea Product

GlobeNewswire - Tue Apr 16, 8:12AM CDT

Itonis, Inc. (OTC:ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce that Itonis Pharmaceuticals plans to offer an oral sublingual spray as a third method of delivery to its recently announced over-the-counter homeopathic nasal spray and nasal swabs for the treatment of nausea.



Active Penny Stock Reports: (OTC Pink: ITNS), (OTCQB: AAMRQ)

ACCESSWIRE-TNW - Sun Mar 31, 4:59PM CDT

New York (March 31st, 2013) - Itonis Inc. (OTC Pink: ITNS) and Charles Hensley, PhD., the inventor of the Zicam(R) cold remedy, announced their initial marketing plans for their over-the-counter homeopathic products for the relief of nausea.



Stocks In The News: (OTC Pink: ITNS), (OTCQB: AAMRQ)

ACCESSWIRE-TNW - Thu Mar 28, 12:31PM CDT

New York (March 28th, 2013) - ITonis Inc. (OTC Pink: ITNS) stock is trading at $0.0061, up 14.81 percent from its previous close. The stock is up with the volume of 145.44 million, substantially higher than its usual volume of 668k shares. ITonis stock opened the session at $0.01. The stock is currently in the bullish mode and is likely to continue the trend as shown by its MACD chart. ITonis commands market capitalization of $1.80 million. The stock trades at beta of 1.54 and is volatile.



(0)
(0)




Itonis Inc. (ITNS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us